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BINDING STUDIES
Synthetic Procedures
OH O Cl
OH Cl
Synthesis of 3,5-dichloro-2,6-dihydroxybenzaldehyde: 4,6-Dichlororesorcinol (1.71 g, 9.57 mmol) was added to a solution of hexamethylenetetramine (2.67 g. 19.1 mmol) in neat trifluoroacetic acid (50.0 mL) under N2 and heated to 70 o C for 12 h. Upon disappearance of starting material, by TLC, 1M HCl (50.0 mL) was added and stirred at 70 o C for an additional 5 hours. The reaction was allowed to cool to room temperature and the precipitate was filtered and dried to yield 3,5-dichloro-1,6-dihydroxy benzaldehyde (1.31 g, 65% yield) as a yellow solid. The product was used without further purification. Physical and spectroscopic data were in agreement with literature reports. 1 
OH O
Synthesis of 3,5-dimethyl-2-hydroxybenzaldehyde: 2,4-Dimethylphenol (1.00 mL, 8.28 mmol) was added to a solution of hexamethylenetetramine (2.32 g, 16.52 mmol) in neat trifluoroacetic acid (50.0 mL) under N2 and heated to 70 o C for 12 h. Upon disappearance of starting material, by TLC, 1M HCl (50.0 mL) was added and the reaction stirred for an additional 3 hours at 100 o C. Upon completion, the reaction was cooled to room temperature and was extracted with dichloromethane (3x20 mL). The resulting organic fractions were combined, washed with brine, dried over sodium sulfate, and concentrated in vacuo. The crude oil was purified via silica gel chromatography (1:9 Ethyl Acetate/Hexanes) to yield 3,5-salicylaldehyde (607 mg, 49% S2 yield) as a yellow liquid. Physical and spectroscopic data were in agreement with literature reports. 2 OH
General procedure for the synthesis of 2-(2-hydroxyphenyl)benzoxazole derivatives: To a solution of Salicylaldehyde derivative (1.0 eq.) in DMF (0.1 M) was added 2-Amino Phenol derivative (1.0 eq.) and was stirred at room temperature. Upon disappearance of starting material, sodium cyanide (1.0 eq.) was added and the reaction was stirred for an additional 18 hours exposed to air. Upon reaction completion, the solution was quenched with 0.1M HCl (10x current volume) and the resulting precipitate was collected via vacuum filtration, dried and used without further purification. 
Expression and Purification of Wild-Type TTR and A108G-TTR
Wild-type TTR and A108G-TTR were prepared as previously described 3, 4 Briefly, both plasmids (pMMHa) were transformed into competent BL21 cells. Two 1L-flasks of LB medium with ampicillin (100 g/mL) were inoculated with fresh 40 mL overnight cultures. Cells were grown at 37C with vigorous shaking until reaching an OD600nm of 0.6. At this point, the cells were induced with 1 mM IPTG and left at the same conditions. Six hours post-induction, cells were harvested and resuspended in 10 mM sodium phosphate buffer (pH 7.6), and lysed by one cycle of freeze (-80C )-thaw, followed by 5 cycles of 3 minutes sonication/3 minutes rest at 4C. Cell debris was removed by centrifugation. Both variants were purified first using ammonium sulfate precipitation. The supernatant was treated with 40% ammonium sulfate, equilibrated for 30 minutes and again collected following centrifugation. The semi-purified 40% supernatants were then precipitated with a 90% ammonium sulfate treatment. The proteins were then dialyzed overnight into 25 mM Tris pH 8.0, 1 mM EDTA with 3000 MW dialysis tubing (Snakeskin from Pierce Biomedical). Both variants were purified on a Source15Q anion exchange column (Amersham Biosciences) eluting with a 200-350 mM NaCl gradient at room temperature, followed by further purification using a gel filtration column (Superdex 75). Proteins were eluted using 10 mM sodium phosphate (pH 7.6), 100 nM KCl, 1 mM EDTA. Both proteins' purity and mass were confirmed by LC-MS analysis (wild-type TTR: 13892; A108G-TTR: 13878). 
Binding Studies of 3 and 5 in A108G Protein
Procedure: 1.0 mL of 5.0 μΜ solution of A108G protein was titrated with sub 1.0 μL injections of stock solutions in DMSO of either 3 or 5, to which the total added DMSO did not exceed 2% of the total solution volume. 1:1 binding isotherms were fit using the Thordson fitting program using. Despite the two binding sites of Transthyretin, Tafamidis binds with negative cooperativity and only one binding isotherm was observed in our studies. Therefore, we found a 1:1 binding isotherm valid for this model. The Ka of 3 into A108G was found to be 9793 M -1 and the Ka of 5 into A108G was found to be 11338 M -1 .
To verify that variations in absorptions were due to binding and not dilution, 5 was titrated into buffered solution and the change in absorption was found to be linear. Thus, we believe observed isotherms are due to binding. Figure S19 . Binding of 3 into 5 μM A108G solution. Inset: Absorbances at four wavelengths. S14 Figure S20 . Binding of 5 into 5 μM A108G solution. Inset: Absorbances at four wavelengths. Figure S21 : Absorbances of 5 in buffer solution at two wavelengths. S15
